Search Results for ''

published presentations and documents on DocSlides.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
Rivaroxaban or Aspirin for Extended Treatment of Venous Thr
by yoshiko-marsland
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban
by celsa-spraggs
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Review on NOACs Studies Dr.
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
R eal-world
R eal-world
by liane-varnes
EVI. dence. on . S. troke prevention . I. n pati...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by giovanna-bartolotta
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Novel Oral Anticoagulants
Novel Oral Anticoagulants
by natalia-silvester
(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
A Multicenter Randomized Trial Evaluating Clinically Signif
A Multicenter Randomized Trial Evaluating Clinically Signif
by ellena-manuel
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
A New Era in Anticoagulation Management
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Dr. Phil Wells  on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators
by yoshiko-marsland
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
A ssessment of  D ual antiplatelet therapy versus
A ssessment of D ual antiplatelet therapy versus
by coursion
R. ivaroxaban . I. n atrial . F. ibrillation patie...
MAGELLAN Primary efficacy endpoint  at 10 days (DVT, symptomatic PE,
MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,
by HoneyBun
VTE death. ) for . rivaroxaban. vs. . enoxaparin....
Reversing Course:  Managing Anticoagulation and Antiplatelet Bleeding
Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding
by kyle585
Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....
P erioperative  management of anticoagulated geriatric patients with
P erioperative management of anticoagulated geriatric patients with
by TinyTeddy
hip fractures. Dr Linda Xu . linda.xu@health.nsw.g...
Bleeding  and cancer risk in patients with vascular
Bleeding and cancer risk in patients with vascular
by danika-pritchard
Bleeding and cancer risk in patients with vascul...
Dodson Thompson, DO
Dodson Thompson, DO
by lois-ondreau
Northlakes. Community Clinic. Minong, WI. Novel ...
Pharmaceutical Management of Cardiac Medications:
Pharmaceutical Management of Cardiac Medications:
by pamella-moone
A Look at New Oral Anticoagulants. Linda Wing, . ...
Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage
Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage
by faustina-dinatale
Fred V. Plapp MD PhD. Pathology and Laboratory Me...
DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag
DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag
by cecilia
Steven Johnston, BDS, MSc, MFDS RCS(Ed), Dental Of...
28 th  August 2022 Ganesan Karthikeyan, Stuart Connolly*,
28 th August 2022 Ganesan Karthikeyan, Stuart Connolly*,
by dorothy
Mpiko. . Ntsekhe. , Bongani . Mayosi. * and Salim...
Anisah Ahmad Pharmacist
Anisah Ahmad Pharmacist
by genevieve
01904 72(4328). Anticoagulants . Warfarin . Novel ...
COMPASS: Show Us the Way for Medical Management of PAD
COMPASS: Show Us the Way for Medical Management of PAD
by miller
Clinical Associate Professor of Medicine. SSM Heal...
New (Direct)Oral  anti-coagulants in the treatment of VTE
New (Direct)Oral anti-coagulants in the treatment of VTE
by ariel
Dr NA Smith - Haematology Dept. Heart of England...
Spotlight  Case New Oral Anticoagulants
Spotlight Case New Oral Anticoagulants
by skylar
This presentation is based on the . December 2013....
The thick and thin of it: Reviewing Anticoagulant Options
The thick and thin of it: Reviewing Anticoagulant Options
by oneill
Lanae Fox, . PharmD. , BCPS. I have no financial d...
Anticoagulation and Thrombosis Management
Anticoagulation and Thrombosis Management
by pasty-toler
Anticoagulation and Thrombosis Management A Revie...
Update in the Perioperative and Emergency Management of Nov
Update in the Perioperative and Emergency Management of Nov
by danika-pritchard
Annelise Gallien, MD FRCPC. Moncton City Hospital...
Update on the New Oral Anticoagulants
Update on the New Oral Anticoagulants
by sherrill-nordquist
Eliot Williams, MD PhD. Division of Hematology &a...
Management of
Management of
by marina-yarberry
Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...